Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Income Common Stock | Net Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -136.78M | -1964.88% | $ 6.96M |
3/31/2025 | $ -131.48M | -2974.08% | $ 4.42M |
12/31/2024 | $ -127.5M | -4527.66% | $ 2.82M |
9/30/2024 | $ -111.3M | -1188.88% | $ 9.36M |
6/30/2024 | $ -104.41M | -855.84% | $ 12.2M |
3/31/2024 | $ -96.8M | -653.5% | $ 14.81M |
12/31/2023 | $ -89.22M | -423.86% | $ 21.05M |
9/30/2023 | $ -88.33M | -521.63% | $ 16.93M |
6/30/2023 | $ -81.58M | -497.14% | $ 16.41M |
3/31/2023 | $ -72.63M | -419.4% | $ 17.32M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Revenues
(=) Net %
Net % for TSCAN THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -26.13M ] / Revenues [ $ 1.08M ]
(=) Net % [ -2408.02% ]
Minimum
Dec 31, 2024
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.19K |
---|---|
min | -63.83% |
max | 69.74% |
average | 4.8% |
median | 5.26% |
std | 19.81% |